1. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression. (1st March 2019) Authors: Luo, Jie; Tian, Jing; Chou, FuJu; Lin, Changyi; Xing, Emily Zixin; Zuo, Li; Niu, Yuanjie; Yeh, Shuyuan; Chang, Chawnshang Journal: Cancer letters Issue: Volume 444(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗